Institutional Ownership Acadia Pharmaceuticals Inc (ACAD)
This table provides information about the institutional ownership of Acadia Pharmaceuticals Inc (ACAD). We have compiled data on the 373 institutions that hold shares in the stock, with a total of 162 Million shares, which have been reported (via 13F filing form) to have a value of $3.9 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Northern Trust Corp
Chicago, IL |
Nov 14, 2025 Q3 2025 |
1,303,536
shares
|
$31.3 Million
0.0% of portfolio
|
Q3 2025
Added 0.07%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Nov 10, 2025 Q3 2025 |
1,204,088
shares
|
$28.9 Million
0.0% of portfolio
|
Q3 2025
Added 1.2%
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2025 Q3 2025 |
1,188,406
shares
|
$28.5 Million
0.0% of portfolio
|
Q3 2025
Reduced 71.09%
|
|
|
Massachusetts Financial Services CO
Boston, MA |
Oct 29, 2025 Q3 2025 |
1,110,726
shares
|
$26.7 Million
0.01% of portfolio
|
Q3 2025
Added 1792.59%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Nov 14, 2025 Q3 2025 |
1,100,883
shares
|
$26.4 Million
0.0% of portfolio
|
Q3 2025
Added 18.53%
|
|
|
Rockefeller Capital Management L.P.
New York, NY |
Nov 14, 2025 Q3 2025 |
1,036,313
shares
|
$24.9 Million
0.05% of portfolio
|
Q3 2025
Reduced 11.0%
|
|
|
Nuveen, LLC
Charlotte, NC |
Nov 12, 2025 Q3 2025 |
953,994
shares
|
$22.9 Million
0.01% of portfolio
|
Q3 2025
Added 13.27%
|
|
|
Prudential Financial Inc
Newark, NJ |
Nov 13, 2025 Q3 2025 |
909,420
shares
|
$21.8 Million
0.02% of portfolio
|
Q3 2025
Added 32.67%
|
|
|
Royal Bank Of Canada
Toronto, A6 |
Nov 14, 2025 Q3 2025 |
900,426
shares
|
$21.6 Million
0.0% of portfolio
|
Q2 2025
Reduced 27.28%
|
|
|
Bank Of America Corp
Charlotte, NC |
Nov 14, 2025 Q3 2025 |
887,848
shares
|
$21.3 Million
0.0% of portfolio
|
Q3 2025
Added 1.09%
|
|
|
Bank Of New York Mellon Corp
New York, NY |
Nov 03, 2025 Q3 2025 |
795,865
shares
|
$19.1 Million
0.0% of portfolio
|
Q3 2025
Reduced 1.3%
|
|
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
Nov 17, 2025 Q3 2025 |
742,078
shares
|
$17.8 Million
0.07% of portfolio
|
Q3 2025
Reduced 2.51%
|
|
|
Invesco Ltd.
Atlanta, GA |
Nov 13, 2025 Q3 2025 |
740,575
shares
|
$17.8 Million
0.0% of portfolio
|
Q3 2025
Reduced 13.68%
|
|
|
Principal Financial Group Inc
Des Moines, IA |
Nov 04, 2025 Q3 2025 |
696,598
shares
|
$16.7 Million
0.01% of portfolio
|
Q3 2025
Reduced 1.91%
|
|
|
Voya Investment Management LLC
Atlanta, GA |
Oct 09, 2025 Q3 2025 |
685,473
shares
|
$16.5 Million
0.02% of portfolio
|
Q3 2025
Added 4.04%
|
|
|
Ameriprise Financial Inc
Minneapolis, MN |
Nov 14, 2025 Q3 2025 |
684,882
shares
|
$16.5 Million
0.0% of portfolio
|
Q3 2025
Added 7.61%
|
|
|
Connor, Clark & Lunn Investment Management Ltd.
|
Nov 13, 2025 Q3 2025 |
668,363
shares
|
$16.1 Million
0.05% of portfolio
|
Q3 2025
Added 4.03%
|
|
|
Two Sigma Investments, LP
New York, NY |
Nov 14, 2025 Q3 2025 |
665,891
shares
|
$16 Million
0.02% of portfolio
|
Q3 2025
Added 37.84%
|
|
|
Ubs Group Ag
|
Nov 13, 2025 Q3 2025 |
664,846
shares
|
$16 Million
0.0% of portfolio
|
Q3 2025
Reduced 9.7%
|
|
|
Panagora Asset Management Inc
Boston, MA |
Nov 13, 2025 Q3 2025 |
656,833
shares
|
$15.8 Million
0.06% of portfolio
|
Q3 2025
Added 0.4%
|
|
|
Ken Fisher
Fisher Asset Management, LLC | Camas, Wa
|
Nov 12, 2025 Q3 2025 |
638,492
shares
|
$15.3 Million
0.01% of portfolio
|
Q3 2025
Added 105.76%
|
|
|
Aqr Capital Management LLC
Greenwich, CT |
Nov 14, 2025 Q3 2025 |
620,832
shares
|
$14.9 Million
0.01% of portfolio
|
Q3 2025
Added 112.83%
|
|
|
Rice Hall James & Associates, LLC
|
Oct 16, 2025 Q3 2025 |
614,937
shares
|
$14.8 Million
0.76% of portfolio
|
Q3 2025
Reduced 8.19%
|
|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
Nov 14, 2025 Q3 2025 |
613,837
shares
|
$14.7 Million
0.55% of portfolio
|
Q3 2025
New holding
|
|
|
Qube Research & Technologies LTD
London, X0 |
Nov 14, 2025 Q3 2025 |
596,442
shares
|
$14.3 Million
0.01% of portfolio
|
Q3 2025
Reduced 23.91%
|
|